|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1994-3-25
|
|
pubmed:abstractText |
To determine whether interferon alfa-2b (IFN-alfa; intron-A, Schering Corp, Kenilworth, NJ) can induce a remission in patients previously treated with active specific immunotherapy (therapeutic melanoma vaccine) without response.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
402-11
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8113848-Adult,
pubmed-meshheading:8113848-Aged,
pubmed-meshheading:8113848-Cancer Vaccines,
pubmed-meshheading:8113848-Female,
pubmed-meshheading:8113848-Humans,
pubmed-meshheading:8113848-Immunotherapy, Active,
pubmed-meshheading:8113848-Interferon-alpha,
pubmed-meshheading:8113848-Male,
pubmed-meshheading:8113848-Melanoma,
pubmed-meshheading:8113848-Middle Aged,
pubmed-meshheading:8113848-Recombinant Proteins,
pubmed-meshheading:8113848-Remission Induction,
pubmed-meshheading:8113848-Tomography, X-Ray Computed,
pubmed-meshheading:8113848-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma.
|
|
pubmed:affiliation |
Department of Medicine, Norris Comprehensive Cancer Center, University of South California School of Medicine, Los Angeles 90033.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
